The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction
Sponsor: Woo Hyun Paik
Terminated
One grade 4 adverse event (AE) and common (47.2%) grade 3 AEs
Listed as NCT03279809, this NA trial focuses on Biliary Stasis, Extrahepatic and remains terminated or withdrawn. Sponsored by Woo Hyun Paik, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2020 — Sep 2020 [monthly]
Recruiting NA
-
Jan 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Woo Hyun Paik
For direct contact, visit the study record on ClinicalTrials.gov .